ã€€ã€€Yinfeng Biological Group Ltd. is responsible for Yinfeng Groupâ€™s technological investment and project operation and management in the biological engineering field. Currently, it is mainly engaged in technological development and service regarding collection, preparation, storage and clinical application of stem cells, cultivation and clinical application of immunological cells and clinical application of gene technology.
ã€€ã€€The company has cooperated in succession with Shandong University School of Medicine, Qilu Hospital of Shandong University, Shandong Provincial Hospital, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Nanjing Military Institute of Medical Sciences. Relying on resources, technologies and talent advantages of Shandong Cord Blood Bank, it has integrated academic research and clinical application and strived to create a first-class exchange platform for high and new biological technologies for cell preparation, cryopreservation and therapy and construct a new industrial cluster for biological engineering and medicine, providing development of human medicine with quality resources and services.
ã€€ã€€Yinfeng Biological has been stressing and strengthening its cooperation with large-scale medical and research institutions in order to create a first-class platform for exchanges of high and new biological technologies, including those for cell preparation, cryopreservation and therapy. Integrating academic research and clinical application, it is also committed to constructing a new biological engineering and medicine cluster to contribute to development of human medicine with quality resources and services.